王者荣耀入口网站登陆

Catalent traded at $95.97 this Friday September 9th, increasing $2.70 or 2.89 percent since the previous trading session. Looking back, over the last four weeks, Catalent gained 14.95 percent. Over the last 12 months, its price fell by 30.28 percent. Looking ahead, we forecast Catalent to be priced at 85.06 by the end of this quarter and at 77.92 in one year, according to 王者荣耀电竞(江西)积分排榜 global macro models projections and analysts expectations.

Stock Price
95.97
Daily Change
2.89%
Yearly
-30.28%

Ok
王者荣耀电竞(江西)积分排榜 members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The 王者荣耀电竞(江西)积分排榜 Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview
Peers Price Day Year
Agilent 137.63 2.44 1.80% -22.34%
AmerisourceBergen 147.27 -0.27 -0.18% 19.92%
Elevance Health Inc 493.60 4.25 0.87% 38.07%
AstraZeneca 10,500.00 -12.00 -0.11% 28.47%
Bristol-Myers Squibb 70.16 0.78 1.12% 11.14%
Bruker 58.29 1.05 1.83% -35.07%
Cigna 292.84 2.13 0.73% 43.07%
Centene 91.99 0.73 0.80% 54.01%
Charles River Laboratories 218.24 4.62 2.16% -50.51%
Catalent 95.97 2.70 2.89% -30.28%
Quest Diagnostics 130.00 -0.20 -0.15% -16.10%
Danaher 290.42 2.32 0.81% -11.99%
Glaxosmithkline 31.89 0.38 1.21% -19.77%
Hologic 69.16 0.29 0.42% -13.54%
Humana 478.50 -7.86 -1.62% 19.04%
Illumina 210.35 3.04 1.47% -54.09%
IQVIA Holdings Inc 223.17 2.05 0.93% -14.33%
Intuitive Surgical 221.32 6.54 3.05% -35.13%
J&J 165.71 0.32 0.19% -0.75%
Lannett 0.48 0.01 2.91% -85.03%
Laboratory Of America 238.32 0.05 0.02% -20.81%
Eli Lilly 317.70 2.20 0.70% 32.65%
Lonza Group 530.20 9.20 1.77% -30.91%
McKesson 366.21 -3.95 -1.07% 80.64%
Allscripts Healthcare Solutions 17.00 0.44 2.66% 18.80%
Merck 174.40 1.65 0.96% -14.47%
Merck & Co 87.34 -0.08 -0.09% 18.91%
Mettler Toledo International 1,300.95 16.64 1.30% -18.38%
Novartis 79.36 0.58 0.74% 0.88%
Pfizer 47.84 0.76 1.61% 4.94%
PerkinElmer 141.62 3.00 2.16% -24.29%
Repligen 233.57 6.39 2.81% -20.83%
Roche Holding 324.25 0.40 0.12% -5.74%
Supernus Pharmaceuticals 34.65 0.10 0.29% 30.31%
Thermo Fisher Scientific 569.40 2.84 0.50% -0.45%
UnitedHealth 524.34 -3.17 -0.60% 29.82%
Waters 312.28 3.66 1.19% -25.68%
West Pharmaceutical Services 313.51 5.38 1.75% -31.70%
Dentsply International 33.96 1.05 3.19% -44.23%

Indexes Price Day Year
US400 2498 43.62 1.78% -7.02%
US500 4067 61.18 1.53% -8.77%

Catalent
Catalent, Inc. provides delivery technologies, and development and manufacturing solutions for drugs; protein, cell, and gene therapy biologics; and consumer health products. Its segments include Softgel and Oral Technologies, Biologics, Oral and Specialty Delivery, and Clinical Supply Services. The Softgel and Oral Technologies segment is engaged in providing formulation, development, and manufacturing services for soft capsules, as well as largescale manufacturing of oral solid dose forms. The Biologics segment provides biologic cell-line, cell therapy and viral vector gene therapy development and manufacturing services. The Oral and Specialty Delivery segment provides formulation development and manufacturing across a range of technologies along with integrated downstream clinical development and commercial supply solutions. The Clinical Supply Services segment is engaged in manufacturing, packaging, distribution and inventory management for drugs and biologics in clinical trials.